首页 > 市场调查报告书 > 医疗设备

生技设备

免疫技能范围专攻领域定序市场:各产品类型，各用途，各终端用户，各地区 - 全球产业洞察，趋势，预测，机会分析，2022年～2028年

市场调查报告书

商品编码

1084611

免疫技能范围专攻领域定序市场:各产品类型，各用途，各终端用户，各地区 - 全球产业洞察，趋势，预测，机会分析，2022年～2028年

Immune Repertoire Sequencing Market, by Product Type, by Application, by End User, and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月11日 | 出版商:

Coherent Market Insights | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

简介目录

本报告提供全球免疫技能范围专攻领域定序市场相关调查，提供市场概要，以及各产品类型，各用途，各终端用户，各地区的趋势，及加入此市场的主要企业简介等资讯。

Immune repertoire refers to sub-type protein that an organism's immune system creates. Immune systems in vertebrates have six key types of proteins- two immunoglobulin and four T cell receptors. Immune repertoire sequencing enables researchers and scientists to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy.

Market Dynamics

Increasing prevalence of cancer worldwide is expected to boost immune repertoire sequencing market growth. According to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. Moreover, the number of people suffering from cancer is expected to reach to 19 million by 2024. According to the Cancer Atlas, 2012, about 1.1 million new cancer cases and 600,000 cancer deaths are reported annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both sexes.

However, factors such as high cost associated with certain sequencing platforms and data analytic services coupled with product recalls are expected to hinder growth of the immune repertoire sequencing market during the forecast period. For instance, in 2015, Illumina Inc. recalled its Illumina MiSeqDx Universal Kit 1.0, due to software limitation when using the product on MiSeqDx instrument. The software could not report insertions or deletions at specific genomic locations with respect to the primer.

Key features of the study:

This report provides in-depth analysis of the immune repertoire sequencing market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global immune repertoire sequencing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Thermo Fisher Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics, Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., and Takara Bio, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global immune repertoire sequencing market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Immune Repertoire Sequencing Market, By Product Type:
- Assay Kits
  - T-Cell Receptor (TCR) Kits
  - B-Cell Receptor (BCR) Kits
- Instruments
Global Immune Repertoire Sequencing Market, By Application:
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Other Applications
Global Immune Repertoire Sequencing Market, By End User:
- Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Others
Global Immune Repertoire Sequencing Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
  - By Product Type:
- Assay Kits
T-Cell Receptor (TCR) Kits
B-Cell Receptor (BCR) Kits
- Instruments
  - By Application:
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Other Applications
  - By End User:
- Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
  - By Product Type:
- Assay Kits
T-Cell Receptor (TCR) Kits
B-Cell Receptor (BCR) Kits
- Instruments
  - By Application:
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Other Applications
  - By End User:
- Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
  - By Product Type:
- Assay Kits
T-Cell Receptor (TCR) Kits
B-Cell Receptor (BCR) Kits
- Instruments
  - By Application:
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Other Applications
  - By End User:
- Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
  - By Product Type:
- Assay Kits
T-Cell Receptor (TCR) Kits
B-Cell Receptor (BCR) Kits
- Instruments
  - By Application:
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Other Applications
  - By End User:
- Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
  - By Product Type:
- Assay Kits
T-Cell Receptor (TCR) Kits
B-Cell Receptor (BCR) Kits
- Instruments
  - By Application:
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Other Applications
  - By End User:
- Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Africa
  - By Country:
- South Africa
- Central Africa
- North Africa
  - By Product Type:
- Assay Kits
T-Cell Receptor (TCR) Kits
B-Cell Receptor (BCR) Kits
- Instruments
  - By Application:
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Other Applications
  - By End User:
- Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
Company Profiles
- Thermo Fisher Scientific, Inc.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Illumina Inc.
- ArcherDX, Inc
- Roche Holding AG
- Pacific Biosciences
- CD Genomics
- Atreca, Inc.
- Adaptive Biotechnologies
- Oxford Nanopore Technologies, Ltd.
- Qiagen N.V.
- Agilent Technologies, Inc.
- Takara Bio, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Landscape
Product Recall
Epidemiology Analysis
Technology Overview
PEST Analysis
Porter's Five Forces model

4. Global Immune Repertoire Sequencing Market, By Product Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Assay Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- T-Cell Receptor (TCR) Kits
- B-Cell Receptor (BCR) Kits
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Immune Repertoire Sequencing Market, By Application, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Cancer Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Biomarker Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Vaccine Development and Efficacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Transplant Rejection and Tolerance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Immune Repertoire Sequencing Market, By End User, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Diagnostic Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Immune Repertoire Sequencing Market, By Region, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
Europe
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Africa
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
Middle East
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East

8. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Illumina Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- ArcherDX, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Roche Holding AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pacific Biosciences
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- CD Genomics
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Atreca, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Adaptive Biotechnologies
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Oxford Nanopore Technologies, Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Qiagen N.V.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Takara Bio, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Analyst Views

9. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

免疫技能范围专攻领域定序市场:各产品类型，各用途，各终端用户，各地区 - 全球产业洞察，趋势，预测，机会分析，2022年～2028年

Immune Repertoire Sequencing Market, by Product Type, by Application, by End User, and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

目录

第1章调查目的·前提条件

第2章市场概要

第3章市场动态，法规，及趋势分析

第4章全球免疫技能范围专攻领域定序市场:各产品类型，2017年～2028年，(100万美元)

第5章全球免疫技能范围专攻领域定序市场:各用途，2017年～2028年，(100万美元)

第6章全球免疫技能范围专攻领域定序市场:各终端用户，2017年～2028年，(100万美元)

第7章全球免疫技能范围专攻领域定序市场:各地区，2017年～2028年，(100万美元)

第8章竞争情形

第9章章节